The Zyprexa Papers

Cover of The Zyprexa Papers by Jim Gottstein
Publisher: Jim Gottstein
Year: 2020
Language: en
Pages: 234
ISBN-13: 9780578627267
Dimensions:
Height: 9 Inches
Length: 6 Inches
Weight: 0.76941329438 Pounds
Width: 0.58 Inches
Editorial overview Touché

The Zyprexa Papers by Jim Gottstein, published by Jim Gottstein on January 26, 2020, is a detailed account of significant legal and ethical issues surrounding the pharmaceutical industry. This edition, comprising 234 pages in English, explores the revelations that emerged from documents obtained by Gottstein, which indicated that Eli Lilly had concealed serious health risks associated with its drug, Zyprexa. The book provides insight into the legal battles that ensued, including allegations of conspiracy and the implications of promoting the drug to vulnerable populations.

Readers will find a thorough examination of the events leading to the exposure of the Zyprexa Papers, including the role of psychiatric survivors in disseminating this critical information. Gottstein presents a clear narrative that delves into the complexities of law, mental health, and medical ethics, offering new details about his advocacy for Bill Bigley, a psychiatric patient central to the story. This book serves as a significant resource for those interested in the intersections of law and mental health, as well as the broader implications of pharmaceutical practices.


Official synopsis Publisher

On December 17, 2006, The New York Times began a series of front-page stories about documents obtained from Alaska lawyer Jim Gottstein, showing Eli Lilly had concealed that its top-selling drug caused diabetes and other life-shortening metabolic problems. The “Zyprexa Papers,” as they came to be known, also showed Eli Lilly was illegally promoting the use of Zyprexa on children and the elderly, with particularly lethal effects. Although Mr. Gottstein believes he obtained the Zyprexa Papers legally, the United States District Court for the Eastern District of New York in Brooklyn decided he had conspired to steal the documents, and Eli Lilly threatened Mr. Gottstein with criminal contempt charges. In The Zyprexa Papers, Mr. Gottstein gives a riveting first-hand account of what really happened, including new details about how a small group of psychiatric survivors spread the Zyprexa Papers on the Internet untraceably. All of this within a gripping, plain-language explanation of complex legal maneuvering and his battles on behalf of Bill Bigley, the psychiatric patient whose ordeal made possible the exposure of the Zyprexa Papers.

FAQ
What is “The Zyprexa Papers” about?
This page includes the available description and bibliographic details for “The Zyprexa Papers” by Jim Gottstein. Synopsis preview: On December 17, 2006, The New York Times began a series of front-page stories about documents obtained from Alaska lawyer Jim Gottstein, showing Eli Lilly had concealed that its top-selling drug caused diabetes and other…
Who is the author of “The Zyprexa Papers”?
“The Zyprexa Papers” is credited to Jim Gottstein.
When was “The Zyprexa Papers” published?
Publisher: Jim Gottstein. Year: 2020.
What is the ISBN for “The Zyprexa Papers”?
ISBN-13: 9780578627267.
What are the book details (language, pages, edition)?
Language: en. Pages: 234.

Related Books by Topic